GLP-1 Market
LLY $1123.00 ▼ -0.1% NVO $44.01 ▼ -1.2% PFE $27.65 ▼ -0.5% VKTX $32.13 ▼ -1.7% KLRA $14.91 ▲ +0.5% GPCR $39.55 ▼ -4.1% RHHBY $53.19 ▼ -0.4% HIMS $27.44 ▼ -1.6% WW $14.78 ▼ -1.1%
Delayed · As of 9:20 AM

Empowering you to have better conversations with your doctor.

Subscribe
About this data Sourced primarily from ClinicalTrials.gov — a listing isn't proof of safety or FDA approval.

Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.

Not yet reported

glepaglutide

Company
Zealand Pharma
Mechanism
Mechanism not yet reported
Route
Route not yet reported
Recruiting trials
1 recruiting

Efficacy results: Not yet reported

Find a Clinical Trial Near Me

1 recruiting study currently listed on ClinicalTrials.gov.

Data source: ClinicalTrials.gov · trial data as of Sep 11, 2026

Find a Clinical Trial Near Me

See recruiting studies for glepaglutide and check eligibility with the study team.

Select conditions
Match
Treatment type

"Added to GLP-1" means the investigational treatment is being studied on top of an existing GLP-1-based therapy.

Your ZIP code is only used to calculate distance to trial sites — it isn't stored.

Trial details
  • Recruiting NCT NCT07197944

    Efficacy And Safety Evaluation of Glepaglutide in Treatment of SBS

    Not yet reported Zealand Pharma 90 participants Est. completion 2032-02-28 31 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03279302

    Trial to Evaluate the PK Profile of Glepaglutide (ZP1848) After a Single IV and After Multiple SC Injections in Healthy Subjects

    Not yet reported Zealand Pharma 75 participants Est. completion 2017-12-18 1 site Stand-alone
    Other conditions: Healthy Subjects
    View official trial listing →
  • Completed NCT NCT03690206

    Efficacy And Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome (SBS)

    Not yet reported Zealand Pharma 106 participants Est. completion 2022-07-26 29 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT03905707

    Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS

    Not yet reported Zealand Pharma 150 participants Est. completion 2026-04-30 27 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04178447

    Pharmacokinetic Profile of Glepaglutide After a Single Injection in Subjects With Varying Degrees of Renal Function

    Not yet reported Zealand Pharma 16 participants Est. completion 2020-07-14 3 sites Stand-alone
    Other conditions: Renal Impairment
    View official trial listing →
  • Completed NCT NCT04318743

    A Bridging Trial to Compare the PK Profile When Glepaglutide is Administered Via Vial/Syringe Versus Autoinjector.

    Not yet reported Zealand Pharma 85 participants Est. completion 2021-06-10 1 site Stand-alone
    Other conditions: Healthy
    View official trial listing →
  • Completed NCT NCT04881825

    Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS - Extension Trial

    Not yet reported Zealand Pharma 84 participants Est. completion 2026-04-30 19 sites Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Completed NCT NCT04991311

    The Long-term Effect on Intestinal Absorption and Safety of Treatment With Glepaglutide in Patients With Short Bowel Syndrome

    Not yet reported Zealand Pharma 12 participants Est. completion 2023-09-05 1 site Stand-alone
    Other conditions: Short Bowel Syndrome
    View official trial listing →
  • Active, not recruiting NCT NCT07228403

    Efficacy and Safety Evaluation of Glepaglutide in Treatment of Short Bowel Syndrome

    Not yet reported Zealand Pharma 28 participants Est. completion 2028-12-31 16 sites Stand-alone
    Other conditions: Short Bowel Syndrome (SBS)
    View official trial listing →
Efficacy history

Not yet reported.

Safety

Not yet reported.

Sources
Related On The Pen coverage

No related coverage yet.

This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.